Search research articles
Contact Us
Filters
Showing results (11-20 of 25) with videos related to
Page
of 3
Sort By:
Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology
|
September 15, 2006
Erratum to "Sparing of the submandibular glands by intensity modulated radiotherapy in the treatment of head and neck cancer" [Radiother. Oncol. 78 (2006) 270-275]
Kauko Saarilahti, Mauri Kouri, Juhani Collan, et al.
Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology
|
March 15, 2005
Intensity modulated radiotherapy for head and neck cancer: evidence for preserved salivary gland function
Kauko Saarilahti, Mauri Kouri, Juhani Collan, et al.
American Journal of Clinical Oncology
|
December 4, 2004
Biweekly escalated, accelerated hyperfractionated radiotherapy with concomitant single-dose mitomycin C results in a high rate of local control in advanced laryngeal and hypopharyngeal cancer
Kauko Saarilahti, Mikael Kajanti, Timo Atula, et al.
Clinical Endocrinology
|
December 31, 2009
Outcome of fractionated stereotactic radiotherapy in patients with pituitary adenomas resistant to conventional treatments: a 5.25-year follow-up study
Camilla Schalin-Jäntti, Leena Valanne, Mikko Tenhunen, et al.
Strahlentherapie Und Onkologie : Organ Der Deutschen Rontgengesellschaft ... [Et Al]
|
July 15, 2015
Converting from CT- to MRI-only-based target definition in radiotherapy of localized prostate cancer: A comparison between two modalities
Tiina Seppälä, Harri Visapää, Juhani Collan, et al.
Journal of Radiation Research
|
July 9, 2009
Acquisition-weighted MRSI for detection and quantification of BNCT 10B-carrier L-p-boronophenylalanine-fructose complex, a phantom study
Marjut Timonen, Leena Kankaanranta, Nina Lundbom, et al.
Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology
|
March 11, 2008
Scintigraphy in prediction of the salivary gland function after gland-sparing intensity modulated radiation therapy for head and neck cancer
Mikko Tenhunen, Juhani Collan, Mauri Kouri, et al.
International Journal of Radiation Oncology, Biology, Physics
|
December 17, 2009
A phase I/II trial of gefitinib given concurrently with radiotherapy in patients with nonmetastatic prostate cancer
Greetta Joensuu, Timo Joensuu, Petri Nokisalmi, et al.
Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology
|
July 9, 2004
Undifferentiated sinonasal carcinoma may respond to single-fraction boron neutron capture therapy
Mauri Kouri, Leena Kankaanranta, Tiina Seppälä, et al.
International Journal of Radiation Oncology, Biology, Physics
|
August 11, 2007
Boron neutron capture therapy in the treatment of locally recurred head and neck cancer
Leena Kankaanranta, Tiina Seppälä, Hanna Koivunoro, et al.
Page
of 3
Search research articles
Search
Showing results (11-20 of 25) with videos related to
Sort By:
Page
of 3
Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology
|
September 15, 2006
Erratum to "Sparing of the submandibular glands by intensity modulated radiotherapy in the treatment of head and neck cancer" [Radiother. Oncol. 78 (2006) 270-275]
Kauko Saarilahti, Mauri Kouri, Juhani Collan, et al.
Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology
|
March 15, 2005
Intensity modulated radiotherapy for head and neck cancer: evidence for preserved salivary gland function
Kauko Saarilahti, Mauri Kouri, Juhani Collan, et al.
American Journal of Clinical Oncology
|
December 4, 2004
Biweekly escalated, accelerated hyperfractionated radiotherapy with concomitant single-dose mitomycin C results in a high rate of local control in advanced laryngeal and hypopharyngeal cancer
Kauko Saarilahti, Mikael Kajanti, Timo Atula, et al.
Clinical Endocrinology
|
December 31, 2009
Outcome of fractionated stereotactic radiotherapy in patients with pituitary adenomas resistant to conventional treatments: a 5.25-year follow-up study
Camilla Schalin-Jäntti, Leena Valanne, Mikko Tenhunen, et al.
Strahlentherapie Und Onkologie : Organ Der Deutschen Rontgengesellschaft ... [Et Al]
|
July 15, 2015
Converting from CT- to MRI-only-based target definition in radiotherapy of localized prostate cancer: A comparison between two modalities
Tiina Seppälä, Harri Visapää, Juhani Collan, et al.
Journal of Radiation Research
|
July 9, 2009
Acquisition-weighted MRSI for detection and quantification of BNCT 10B-carrier L-p-boronophenylalanine-fructose complex, a phantom study
Marjut Timonen, Leena Kankaanranta, Nina Lundbom, et al.
Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology
|
March 11, 2008
Scintigraphy in prediction of the salivary gland function after gland-sparing intensity modulated radiation therapy for head and neck cancer
Mikko Tenhunen, Juhani Collan, Mauri Kouri, et al.
International Journal of Radiation Oncology, Biology, Physics
|
December 17, 2009
A phase I/II trial of gefitinib given concurrently with radiotherapy in patients with nonmetastatic prostate cancer
Greetta Joensuu, Timo Joensuu, Petri Nokisalmi, et al.
Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology
|
July 9, 2004
Undifferentiated sinonasal carcinoma may respond to single-fraction boron neutron capture therapy
Mauri Kouri, Leena Kankaanranta, Tiina Seppälä, et al.
International Journal of Radiation Oncology, Biology, Physics
|
August 11, 2007
Boron neutron capture therapy in the treatment of locally recurred head and neck cancer
Leena Kankaanranta, Tiina Seppälä, Hanna Koivunoro, et al.
Page
of 3